LoDoCo2
Low-dose colchicine for secondary prevention of cardiovascular disease – LoDoCo2 trial
- Stadium
- klaar
- Middel
- colchicine
- Populatie
- ASCVD
- Fase
- III
- First Patient In
- 24 november 2016
- Last Patient In
- 3 december 2018
- Last Patient Last Visit
- 14 februari 2020
National Lead
prof. dr. J.H. Cornel
Cardioloog
Studiedirecteur
